Epizyme, Inc.
SUBSTITUTED 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
Last updated:
Abstract:
The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.
Status:
Application
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
8 Oct 2020